FKetek (Telithromycin) in an antibiotic prescribed for the treatment of a variety of respiratory infections including: bronchitis, sinusitis and pneumonia. Ketek is manufactured by Sanofi- Aventis and approved by the FDA in 2004,
In 2006, cases of severe liver problems including one death were associated with Ketek. These cases all occurred within the same hospital in North Carolina. Later the same year 110 cases of liver problems were connected to Ketek, including four deaths. Ketek is also linked to drug-induced hepatitis.
Together with Congress, the FDA began investigating the possible lethal side effects associated with Ketek. As a result of this investigation, the manufacturers of Ketek were required to place additional warning information on the drug label effective June 29, 2006.
Symptoms of abnormal liver function include fatigue, loss of appetite, nausea, yellow skin (jaundice), and dark colored urine. If you have taken Ketek and have experienced any of these symptoms, you can contact us for further investigation into your potential claim.
